Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma

被引：0
作者：
Yanming Zhou
Xiaofeng Zhang
Lupeng Wu
Feng Ye
Xu Su
Lehua Shi
Bin Li
机构：
[1] First affiliated Hospital of Xiamen University; Oncologic Center of Xiamen,Department of Hepatobiliary & Pancreatovascular Surgery
[2] Second Military Medical University,Department IV of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital
来源：
BMC Gastroenterology | / 13卷
关键词：
Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
    Mao, Jiaren
    Tan, Zhongjun
    Pan, Xiaoqi
    Meng, Feijian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [42] Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
    Hatanaka, Takeshi
    Arai, Hirotaka
    Kakizaki, Satoru
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (07) : 485 - 495
  • [43] Impact of Sarcopenia on Prognosis in Primary Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Single Center Retrospective Study
    Bai, Yaowei
    Liu, Jiacheng
    Wang, Ying
    Zhou, Binqian
    Liu, Xiaoming
    Dong, Xiangjun
    Zheng, Chuansheng
    JOURNAL OF CANCER, 2024, 15 (07): : 1837 - 1847
  • [44] Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis
    Zhou, Luke
    Zhang, Mao
    Chen, Siyu
    ANNALS OF HEPATOLOGY, 2023, 28 (02)
  • [45] Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma
    Guo, Yuan
    Li, Ru-Chun
    Xia, Wei-Li
    Yang, Xiong
    Zhu, Wen-Bo
    Li, Fang-Ting
    Hu, Hong-Tao
    Li, Hai-Liang
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (07)
  • [46] Comparison of stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Systematic review and meta-analysis
    Komiyama, Satoshi
    Takeda, Atsuya
    Tateishi, Yudai
    Tsurugai, Yuichiro
    Eriguchi, Takahisa
    Horita, Nobuyuki
    RADIOTHERAPY AND ONCOLOGY, 2025, 202
  • [47] Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction
    Kaibori, Masaki
    Tanigawa, Noboru
    Matsui, Yoichi
    Saito, Takamichi
    Uchida, Yoichiro
    Ishizaki, Morihiko
    Tanaka, Hironori
    Kamiyama, Yasuo
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3685 - 3692
  • [48] Treatment outcomes of transcatheter arterial chemoembolization combined with local ablative therapy versus monotherapy in hepatocellular carcinoma: a meta-analysis
    Gu, Lili
    Liu, Huiling
    Fan, Linlin
    Lv, Yuanjun
    Cui, Zhuang
    Luo, Yan
    Liu, Yuanyuan
    Li, Guang
    Li, Changping
    Ma, Jun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (02) : 199 - 210
  • [49] Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Yamashita, F
    Tanaka, M
    Andou, E
    Yutani, S
    Kato, O
    Tanikawa, K
    ONCOLOGY, 1997, 54 (01) : 28 - 33
  • [50] Transcatheter Arterial Chemoembolization in Combination With High-Intensity Focused Ultrasound for Intermediate and Advanced Hepatocellular Carcinoma: A Meta-Analysis
    Wang, Yun-Bing
    Ma, Rong
    Wang, Zhi-Biao
    Shi, Qiu-Ling
    Zhang, Lian
    Chen, Wen-Zhi
    Gong, Jian-Ping
    Bai, Jin
    FRONTIERS IN ONCOLOGY, 2022, 12
12345